Page last updated: 2024-10-30

tetramisole and Amyotrophic Lateral Sclerosis

tetramisole has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole : An imidazothiazole that is imidazo[2,1-b][1,3]thiazole in which the double bonds at the 2-3 and 5-6 positions have been reduced to single bonds and in which one of the hydrogens at position 6 is replaced by a phenyl group.
tetramisole : A racemate comprising equimolar amounts of levamisole and dexamisole.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baugh, SD1
Morrice, JR1
Reitz, AB1
Shaw, CA1
Gregory-Evans, CY1

Other Studies

1 other study available for tetramisole and Amyotrophic Lateral Sclerosis

ArticleYear
Levamisole derivatives as immune modulators for the treatment of amyotrophic lateral sclerosis (ALS).
    Future medicinal chemistry, 2023, Volume: 15, Issue:8

    Topics: Amyotrophic Lateral Sclerosis; Cytokines; Humans; Levamisole; Tetramisole

2023